Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
News Topics
- (-) Biotechnology (3)
- 3-D Printing/Advanced Manufacturing (9)
- Advanced Reactors (2)
- Artificial Intelligence (11)
- Big Data (3)
- Bioenergy (5)
- Biology (7)
- Biomedical (2)
- Buildings (3)
- Chemical Sciences (8)
- Climate Change (12)
- Composites (2)
- Computer Science (8)
- Coronavirus (2)
- Critical Materials (1)
- Cybersecurity (3)
- Decarbonization (8)
- Education (3)
- Energy Storage (7)
- Environment (8)
- Exascale Computing (3)
- Frontier (4)
- Fusion (2)
- Grid (3)
- High-Performance Computing (13)
- Isotopes (2)
- Machine Learning (4)
- Materials (28)
- Materials Science (7)
- Microscopy (4)
- Molten Salt (1)
- Nanotechnology (2)
- National Security (4)
- Net Zero (2)
- Neutron Science (8)
- Nuclear Energy (5)
- Partnerships (18)
- Physics (4)
- Polymers (1)
- Quantum Computing (3)
- Quantum Science (4)
- Renewable Energy (1)
- Security (2)
- Simulation (7)
- Summit (2)
- Sustainable Energy (2)
- Transportation (5)
Media Contacts
Four scientists affiliated with ORNL were named Battelle Distinguished Inventors during the lab’s annual Innovation Awards on Dec. 1 in recognition of being granted 14 or more United States patents.
In a discovery aimed at accelerating the development of process-advantaged crops for jet biofuels, scientists at ORNL developed a capability to insert multiple genes into plants in a single step.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.